| Let’s talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine M Linxweiler, B Schick, R Zimmermann Signal transduction and targeted therapy 2 (1), 1-10, 2017 | 167 | 2017 |
| The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype M Linxweiler, F Kuo, N Katabi, M Lee, Z Nadeem, MG Dalin, V Makarov, ... Clinical Cancer Research 26 (12), 2859-2870, 2020 | 91 | 2020 |
| Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in … M Linxweiler, S Schorr, N Schäuble, M Jung, J Linxweiler, F Langer, ... BMC cancer 13, 1-14, 2013 | 90 | 2013 |
| Sec62 bridges the gap from 3q amplification to molecular cell biology in non–small cell lung cancer M Linxweiler, J Linxweiler, M Barth, J Benedix, V Jung, YJ Kim, RM Bohle, ... The American journal of pathology 180 (2), 473-483, 2012 | 85 | 2012 |
| Vitamin D deficiency in head and neck cancer patients–prevalence, prognostic value and impact on immune function F Bochen, B Balensiefer, S Körner, JT Bittenbring, F Neumann, A Koch, ... Oncoimmunology 7 (9), e1476817, 2018 | 70 | 2018 |
| Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas F Bochen, H Adisurya, S Wemmert, C Lerner, M Greiner, R Zimmermann, ... Oncotarget 8 (3), 4922, 2017 | 41 | 2017 |
| Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration C Lerner, S Wemmert, F Bochen, P Kulas, M Linxweiler, A Hasenfus, ... Journal of cancer research and clinical oncology 142, 757-766, 2016 | 41 | 2016 |
| Combination of p16INK4a/Ki67 immunocytology and hpv polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer M Linxweiler, F Bochen, S Wemmert, C Lerner, A Hasenfus, RM Bohle, ... Cancer cytopathology 123 (4), 219-229, 2015 | 39 | 2015 |
| Complexity and specificity of Sec61-channelopathies: human diseases affecting gating of the Sec61 complex M Sicking, S Lang, F Bochen, A Roos, JPH Drenth, M Zakaria, ... Cells 10 (5), 1036, 2021 | 36 | 2021 |
| Impact of different intraoperative CO2 pressure levels (8 and 15 mmHg) during laparoscopic hysterectomy performed due to benign uterine pathologies on postoperative pain … JC Radosa, MP Radosa, PA Schweitzer, CG Radosa, L Stotz, A Hamza, ... BJOG: An International Journal of Obstetrics & Gynaecology 126 (10), 1276-1285, 2019 | 36 | 2019 |
| Cancer of unknown primary (CUP) of the head and neck: retrospective analysis of 81 patients B Al Kadah, G Papaspyrou, M Linxweiler, B Schick, C Rübe, BS Büchler, ... European Archives of Oto-Rhino-Laryngology 274, 2557-2566, 2017 | 36 | 2017 |
| Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions M Linxweiler, F Bochen, B Schick, S Wemmert, B Al Kadah, M Greiner, ... BMC cancer 16, 1-12, 2016 | 35 | 2016 |
| HPV status as prognostic biomarker in head and neck cancer—which method fits the best for outcome prediction? JP Kühn, W Schmid, S Körner, F Bochen, S Wemmert, H Rimbach, ... Cancers 13 (18), 4730, 2021 | 28 | 2021 |
| Treatment of SEC62 over-expressing tumors by Thapsigargin and Trifluoperazine C Körbel, M Linxweiler, F Bochen, S Wemmert, B Schick, M Meyer, ... Biomolecular Concepts 9 (1), 53-63, 2018 | 26 | 2018 |
| Augmented reality‐enhanced navigation in endoscopic sinus surgery: a prospective, randomized, controlled clinical trial M Linxweiler, L Pillong, D Kopanja, JP Kühn, S Wagenpfeil, JC Radosa, ... Laryngoscope Investigative Otolaryngology 5 (4), 621-629, 2020 | 25 | 2020 |
| Identification of 3q oncogene SEC62 as a marker for distant metastasis and poor clinical outcome in invasive ductal breast cancer FZ Takacs, JC Radosa, M Linxweiler, M Kasoha, RM Bohle, F Bochen, ... Archives of Gynecology and Obstetrics 299, 1405-1413, 2019 | 23 | 2019 |
| Noninvasive histological imaging of head and neck squamous cell carcinomas using confocal laser endomicroscopy M Linxweiler, BA Kadah, A Bozzato, V Bozzato, A Hasenfus, YJ Kim, ... European Archives of Oto-Rhino-Laryngology 273, 4473-4483, 2016 | 18 | 2016 |
| Expression of SEC62 Oncogene in Benign, Malignant and Borderline Melanocytic Tumors—Unmasking the Wolf in Sheep’s Clothing? CSL Müller, C Pföhler, M Wahl, F Bochen, S Körner, JP Kühn, A Bozzato, ... Cancers 13 (7), 1645, 2021 | 13 | 2021 |
| Expression of 3q oncogene SEC62 in atypical fibroxanthoma‑immunohistochemical analysis of 41 cases and correlation with clinical, viral and histopathologic features CSL Müller, L Kreie, F Bochen, T Pfuhl, S Smola, S Gräber, T Vogt, ... Oncology Letters 17 (2), 1768-1776, 2019 | 13 | 2019 |
| SEC62 and SEC63 expression in hepatocellular carcinoma and tumor-surrounding liver tissue M Casper, M Linxweiler, J Linxweiler, R Zimmermann, M Glanemann, ... Visceral Medicine 37 (2), 110-115, 2021 | 12 | 2021 |
Richard ZimmermannSaarland University在 uks.eu 的电子邮件经过验证
Richard ZimmermannSaarland University在 uks.eu 的电子邮件经过验证
Luc MorrisMSKCC在 mskcc.org 的电子邮件经过验证